日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study

利伐沙班用于门诊胰腺癌患者的血栓预防:一项随机CASSINI研究的预设亚组分析结果

Vadhan-Raj, Saroj; McNamara, Mairéad G; Venerito, Marino; Riess, Hanno; O'Reilly, Eileen M; Overman, Michael J; Zhou, Xiao; Vijapurkar, Ujjwala; Kaul, Simrati; Wildgoose, Peter; Khorana, Alok A

A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer

一项关于晚期癌症患者药物相关性颌骨坏死的多中心病例登记研究

Schiodt, Morten; Vadhan-Raj, Saroj; Chambers, Mark S; Nicolatou-Galitis, Ourania; Politis, Constantinus; Coropciuc, Ruxandra; Fedele, Stefano; Jandial, Danielle; Zhang, Jeffrey; Ma, Haijun; Saunders, Deborah P

A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia

一项针对癌症相关性贫血的肝素单克隆抗体LY2787106的首次人体I期研究

Vadhan-Raj, Saroj; Abonour, Rafat; Goldman, Jonathan W; Smith, David A; Slapak, Christopher A; Ilaria, Robert L Jr; Tiu, Ramon V; Wang, Xuejing; Callies, Sophie; Cox, Joanne; Tuttle, Jay L; Lau, Yiu-Keung; Roeland, Eric J

Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial

利伐沙班用于预防高危门诊癌症患者静脉血栓栓塞:CASSINI试验的原理和设计。CASSINI试验的原理和设计

Khorana, Alok A; Vadhan-Raj, Saroj; Kuderer, Nicole M; Wun, Ted; Liebman, Howard; Soff, Gerald; Belani, Chandra; O'Reilly, Eileen M; McBane, Robert; Eikelboom, John; Damaraju, C V; Beyers, Karen; Dietrich, Flavia; Kakkar, Ajay K; Riess, Hanno; Peixoto, Renata D'Alpino; Lyman, Gary H

Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion

高累积剂量多柔比星持续输注治疗肉瘤患者后,早期出现心脏毒性和肿瘤反应的证据

Quintana, Raymundo A; Banchs, Jose; Gupta, Ridhi; Lin, Heather Y; Raj, Sean D; Conley, Anthony; Ravi, Vinod; Araujo, Dejka; Benjamin, Robert S; Patel, Shreyaskumar; Vadhan-Raj, Saroj; Somaiah, Neeta

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

评估一项随机3期试验中接受地诺单抗或唑来膦酸治疗的多发性骨髓瘤患者亚组的结果

Raje, N; Vadhan-Raj, S; Willenbacher, W; Terpos, E; Hungria, V; Spencer, A; Alexeeva, Y; Facon, T; Stewart, A K; Feng, A; Braun, A; Balakumaran, A; Roodman, G D

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study

一项 III 期、开放标签、6 个月扩展研究的结果显示,ferumoxytol 用于治疗既往口服铁剂治疗效果不佳的缺铁性贫血患者的间歇性缺铁性贫血的安全性和有效性。

Vadhan-Raj, Saroj; Ford, David C; Dahl, Naomi V; Bernard, Kristine; Li, Zhu; Allen, Lee F; Strauss, William E

Clinical applications of palifermin: amelioration of oral mucositis and other potential indications

帕利弗明的临床应用:改善口腔黏膜炎及其他潜在适应症

Vadhan-Raj, Saroj; Goldberg, Jenna D; Perales, Miguel-Angel; Berger, Dietmar P; van den Brink, Marcel R M

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

一项针对有肿瘤溶解综合征风险患者的随机试验,比较单剂量拉布立酶与每日五次给药的疗效

Vadhan-Raj, S; Fayad, L E; Fanale, M A; Pro, B; Rodriguez, A; Hagemeister, F B; Bueso-Ramos, C E; Zhou, X; McLaughlin, P W; Fowler, N; Shah, J; Orlowski, R Z; Samaniego, F; Wang, M; Cortes, J E; Younes, A; Kwak, L W; Sarlis, N J; Romaguera, J E

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results

局部晚期乳腺癌患者接受剂量强化新辅助化疗联合或不联合粒细胞集落刺激因子(G-CSF)治疗的III期随机试验:长期结果

Arun, Banu K; Dhinghra, Kapil; Valero, Vicente; Kau, Shu-Wan; Broglio, Kristine; Booser, Daniel; Guerra, Laura; Yin, Guosheng; Walters, Ronald; Sahin, Aysegul; Ibrahim, Nuhad; Buzdar, Aman U; Frye, Debbie; Sneige, Nour; Strom, Eric; Ross, Merrick; Theriault, Richard L; Vadhan-Raj, Saroj; Hortobagyi, Gabriel N